Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...
TECregen seed funding supports the development of thymus regeneration biologics designed to restore immune function and ...
Immune protection fades with time, and much of that decline traces back to the thymus. This small organ, located in front of the heart, trains new T cells and releases signals that help them survive.
Scientists hoping to discover better ways to boost immune function — which could lengthen our healthspan and protect immunocompromised patients — may have a new target, according to findings published ...
Morning Overview on MSN
Experimental mRNA therapy reverses immune-cell aging in mice
Researchers have used an experimental mRNA therapy to make old immune cells in mice behave as if they were young again, ...
PHILADELPHIA--(BUSINESS WIRE)--Tolerance Bio, Inc., a biopharmaceutical company pioneering a novel approach to increasing healthspan by preserving, restoring, and manipulating the function of the ...
City of Hope® Research Spotlight features the latest research defining the future of medical treatment. This first roundup highlights a T cell engager that shows promise as a novel treatment for acute ...
HOUSTON, June 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (FBLG), ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback